MedTrace Logo

Thermal Imaging to Evaluate Skin Toxicity From Radiotherapy

NCT04013711 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 200

Last updated 2023-04-11

No results posted yet for this study

Summary

A significant proportion of patients treated with whole-breast or head and neck radiotherapy will experience skin toxicity, i.e. skin dermatitis, which may lead to erythema, dry desquamation and wet desquamation. It is hypothesized that quantitative thermal imaging can be used to measure radiation-induced skin toxicity.

Conditions

  • Radiotherapy Side Effect
  • Radiodermatitis

Interventions

DIAGNOSTIC_TEST

Thermography

Thermograms will be acquired of both treated and non-treated cancer site for comparison.

Sponsors & Collaborators

  • Sunnybrook Health Sciences Centre

    lead OTHER

Principal Investigators

  • William T Tran, PhD · Clinician Scientist

Study Design

Allocation
NA
Purpose
DIAGNOSTIC
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2018-08-01
Primary Completion
2021-12-30
Completion
2022-07-19

Countries

  • Canada

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04013711 on ClinicalTrials.gov